Desktop Site
|
28 Mar 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Watch List
Get Quote
Notices
|
S&P
BSE SENSEX
73,651.35
+655.04
+0.90 %
Corporate Announcement
Security Code
532296
Company
GLENMARK PHARMACEUTICALS LTD.
Exchange Received Time
26/02/2019 08:52:20
Exchange Disseminated Time
26/02/2019 08:52:23
Time Taken
00:00:03
Announcement under Regulation 30 (LODR)-Press Release / Media Release |
2/26/2019 8:52:21 AM
Glenmark Pharmaceuticals Announces Results from New Analysis of Pooled Data on Ryaltris™, an Investigational Product for the Treatment of Seasonal Allergic Rhinitis, at the AAAAI 2019 Annual Meeting.
Attachment
<< Back
Recently Viewed